ASX:HLA

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Healthia Limited provides health services in Australia. More Details


Snowflake Analysis

Slightly overvalued with limited growth.

Share Price & News

How has Healthia's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: HLA has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

-0.5%

HLA

-2.1%

AU Healthcare

0.3%

AU Market


1 Year Return

4.1%

HLA

4.0%

AU Healthcare

-5.4%

AU Market

Return vs Industry: HLA matched the Australian Healthcare industry which returned 4.4% over the past year.

Return vs Market: HLA exceeded the Australian Market which returned -5.7% over the past year.


Shareholder returns

HLAIndustryMarket
7 Day-0.5%-2.1%0.3%
30 Day-2.4%2.4%6.3%
90 Day3.6%5.3%3.7%
1 Year6.2%4.1%6.0%4.0%-2.1%-5.4%
3 Yearn/a21.9%12.1%18.3%3.3%
5 Yearn/a28.4%10.9%43.1%14.0%

Price Volatility Vs. Market

How volatile is Healthia's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Healthia undervalued compared to its fair value and its price relative to the market?

12.4%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: HLA (A$1.01) is trading below our estimate of fair value (A$1.15)

Significantly Below Fair Value: HLA is trading below fair value, but not by a significant amount.


Price To Earnings Ratio

PE vs Industry: HLA is good value based on its PE Ratio (23.7x) compared to the AU Healthcare industry average (29.8x).

PE vs Market: HLA is poor value based on its PE Ratio (23.7x) compared to the Australian market (21.5x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate HLA's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: HLA's PB Ratio (1.5x) is in line with the AU Healthcare industry average.


Next Steps

Future Growth

How is Healthia forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

20.7%

Forecasted annual revenue growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if HLA's forecast earnings growth is above the savings rate (2.3%).

Earnings vs Market: Insufficient data to determine if HLA's earnings are forecast to grow faster than the Australian market

High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: HLA's revenue (20.7% per year) is forecast to grow faster than the Australian market (4.7% per year).

High Growth Revenue: HLA's revenue (20.7% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if HLA's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has Healthia performed over the past 5 years?

-33.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: HLA has a large one-off gain of A$5.2M impacting its June 30 2020 financial results.

Growing Profit Margin: HLA became profitable in the past.


Past Earnings Growth Analysis

Earnings Trend: HLA's earnings have declined by 33.3% per year over the past 5 years.

Accelerating Growth: HLA has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: HLA has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (-6.1%).


Return on Equity

High ROE: HLA's Return on Equity (8.9%) is considered low.


Next Steps

Financial Health

How is Healthia's financial position?


Financial Position Analysis

Short Term Liabilities: HLA's short term assets (A$15.2M) do not cover its short term liabilities (A$21.8M).

Long Term Liabilities: HLA's short term assets (A$15.2M) do not cover its long term liabilities (A$49.6M).


Debt to Equity History and Analysis

Debt Level: HLA's debt to equity ratio (46.6%) is considered high.

Reducing Debt: Insufficient data to determine if HLA's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: HLA's debt is well covered by operating cash flow (64.3%).

Interest Coverage: HLA's interest payments on its debt are not well covered by EBIT (1.8x coverage).


Balance Sheet


Next Steps

Dividend

What is Healthia current dividend yield, its reliability and sustainability?

1.98%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: HLA's dividend (1.98%) isn’t notable compared to the bottom 25% of dividend payers in the Australian market (2.14%).

High Dividend: HLA's dividend (1.98%) is low compared to the top 25% of dividend payers in the Australian market (5.48%).


Stability and Growth of Payments

Stable Dividend: Too early to tell whether HLA's dividend payments have been stable as they only just started paying a dividend.

Growing Dividend: Too early to tell if HLA's dividend payments are increasing as they only just started paying a dividend.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (46.8%), HLA's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: HLA's dividends in 3 years are forecast to be well covered by earnings (31.9% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.5yrs

Average management tenure


CEO

Wes Coote

1.5yrs

Tenure

AU$313,230

Compensation

Mr. Wesley James Coote, also known as Wes, B.Com., C.A., ACIS, serves as the Managing Director of Evolve Salons Limited. Mr. Coote has been Group Managing Director, Chief Executive Officer and Director at ...


CEO Compensation Analysis

Compensation vs Market: Wes's total compensation ($USD220.90K) is about average for companies of similar size in the Australian market ($USD275.98K).

Compensation vs Earnings: Wes's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Wesley Coote
Group MD1.5yrsAU$313.23k2.43%
A$ 1.6m
Christopher Banks
CFO & Company Secretary1.5yrsAU$218.49k0.53%
A$ 338.6k
Anthony Ganter
Group COO & Executive Directorno dataAU$247.59k1.42%
A$ 908.4k
Dean Hartley
Chief Technology Officerno dataAU$222.71k5.89%
A$ 3.8m
Darren Stewart
Director of Podiatry & Executive Director2.42yrsAU$193.20k12.37%
A$ 7.9m
Kerrie Evans
Group Chief Education & Research Officerno datano datano data

1.5yrs

Average Tenure

Experienced Management: HLA's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Wesley Coote
Group MD1.5yrsAU$313.23k2.43%
A$ 1.6m
Anthony Ganter
Group COO & Executive Directorno dataAU$247.59k1.42%
A$ 908.4k
Darren Stewart
Director of Podiatry & Executive Director2.42yrsAU$193.20k12.37%
A$ 7.9m
Glen Richards
Non-Executive Chairman2.42yrsAU$77.65k7.85%
A$ 5.0m
Paul Wilson
Independent Non-Executive Director2.42yrsAU$47.50k0.62%
A$ 397.1k
Lisa Dalton
Independent Non-Executive Director2.42yrsAU$47.50k0.035%
A$ 22.4k

2.4yrs

Average Tenure

Experienced Board: HLA's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: HLA insiders have sold more shares than they have bought in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2%.


Top Shareholders

Company Information

Healthia Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Healthia Limited
  • Ticker: HLA
  • Exchange: ASX
  • Founded: 2018
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: AU$63.984m
  • Shares outstanding: 64.31m
  • Website: https://www.healthia.com.au

Location

  • Healthia Limited
  • East Tower
  • Level 4
  • Bowen Hills
  • Queensland
  • 4006
  • Australia

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
HLAASX (Australian Securities Exchange)YesOrdinary SharesAUAUDSep 2018
HLACHIA (Chi-X Australia)YesOrdinary SharesAUAUDSep 2018

Biography

Healthia Limited provides health services in Australia. The company operates 72 podiatry clinics under the My FootDr brand; 23 physiotherapy clinics under the Allsports Physiotherapy brand; and 7 hand ther ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/10/21 10:41
End of Day Share Price2020/10/21 00:00
Earnings2020/06/30
Annual Earnings2020/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.